Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' STRYCKMANS P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 76 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ho, AD; Suciu, S; Stryckmans, P; De Cataldo, F; Willemze, R; Thaler, J; Peetermans, M; Dohner, H; Solbu, G; Dardenne, M; Zittoun, R
      Pentostatin (Nipent) in T-cell malignancies

      SEMINARS IN ONCOLOGY
    2. Ho, AD; Suciu, S; Stryckmans, P; De Cataldo, F; Willemze, R; Thaler, J; Peetermans, M; Dohner, H; Solbu, G; Dardenne, M; Zittoun, R
      Pentostatin in T-cell malignancies - a phase II trial of the EORTC

      ANNALS OF ONCOLOGY
    3. LAGNEAUX L; DELFORGE L; BERNIER M; STRYCKMANS P; BRON D
      TGF-BETA ACTIVITY AND EXPRESSION OF ITS RECEPTORS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA

      Leukemia & lymphoma
    4. TRENSCHEL R; BERNIER M; DELFORGE A; MASSY M; DEHEMRICOURT EL; MAEREVOET M; BADJOU R; STRYCKMANS P; BRON D
      MYELOID AND LYMPHOID RECOVERY FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - A COMPARATIVE-STUDY BETWEEN RELATED, UNRELATED BONE-MARROWAND ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION

      Leukemia & lymphoma
    5. BLEIBERG H; DUCHATEAU J; MBON JBN; GERARD B; BRON D; DEBUSSCHER L; STRYCKMANS P
      INCREASED INCIDENCE OF LYMPHOMAS AND CARCINOMAS IN PATIENTS WITH CELIAC-DISEASE

      European journal of cancer
    6. LOWENBERG B; SUCIU S; ARCHIMBAUD E; HAAK H; STRYCKMANS P; DECATALDO R; DEKKER AW; BERNEMAN ZN; THYSS A; VANDERLELIE J; SONNEVELD P; VISANI G; FILLET G; HAYAT M; HAGEMEIJER A; SOLBU G; ZITTOUN R
      MITOXANTRONE VERSUS DAUNORUBICIN IN INDUCTION-CONSOLIDATION CHEMOTHERAPY - THE VALUE OF LOW-DOSE CYTARABINE FOR MAINTENANCE OF REMISSION, AND AN ASSESSMENT OF PROGNOSTIC FACTORS IN ACUTE MYELOID-LEUKEMIA IN THE ELDERLY - FINAL REPORT OF THE LEUKEMIA COOPERATIVE GROUP OF THE ANIZATION-FOR-THE-RESEARCH-AND-TREATMENT-OF-CANCER AND THE DUTCH-BELGIAN HEMATOONCOLOGY COOPERATIVE HOVON GROUP RANDOMIZED PHASE-III STUDY AML-9

      Journal of clinical oncology
    7. BRON D; DELFORGE A; BOSMANS E; BRUGGEMAN C; SNOECK R; DECLERCQ E; STRYCKMANS P; LAGNEAUX L
      DYSREGULATION OF CYTOKINE PRODUCTION BY BONE-MARROW STROMAL CELLS AFTER EXPOSURE TO HUMAN CYTOMEGALOVIRUS (HUCMV) OR RECOMBINANT PROTEINS OF HUCMV

      British Journal of Haematology
    8. BRON D; MEULEMAN N; DEBRUYNE JM; MAEREVOET M; RIZOPOULO H; STRYCKMANS P
      CMV INFECTION AND DISEASE IN 100 ALLOGENEIC BMT PATIENTS - FROM NO PROPHYLAXIS TO PREEMPTIVE TREATMENT

      British Journal of Haematology
    9. LAGNEAUX L; DELFORGE A; BRON D; DEBRUYN C; STRYCKMANS P
      CHRONIC LYMPHOCYTIC LEUKEMIC B-CELLS BUT NOT NORMAL B-CELLS ARE RESCUED FROM APOPTOSIS BY CONTACT WITH NORMAL BONE-MARROW STROMAL CELLS

      Blood
    10. DEBRUYN C; DELFORGE A; BRON D; BERNIER M; MASSY M; DEHEMPTINNE D; STRYCKMANS P
      EX-VIVO EXPANSION OF CD34- CORD-BLOOD CELLS(CD38)

      Journal of hematotherapy
    11. WILLEMZE R; SUCIU S; ARCHIMBAUD E; MUUS P; STRYCKMANS P; LOUWAGIE EA; BERNEMAN Z; TJEAN M; WIJERMANS P; DOHNER H; JEHN U; LABAR B; JAKSIC B; DARDENNE M; ZITTOUN R
      A RANDOMIZED PHASE-II STUDY ON THE EFFECTS OF 5-AZA-2'-DEOXYCYTIDINE COMBINED WITH EITHER AMSACRINE OR IDARUBICIN IN PATIENTS WITH RELAPSEDACUTE-LEUKEMIA - AN EORTC LEUKEMIA COOPERATIVE GROUP PHASE-II STUDY-(06893)

      Leukemia
    12. DEBRUYN C; DELFORGE A; BRON D; STRYCKMANS P
      CELL-CYCLE STATUS OF CD34(-CORD BLOOD, BONE-MARROW AND MOBILIZED PERIPHERAL-BLOOD BEFORE AND AFTER CYTOKINE STIMULATION() SUBPOPULATIONS FROM UMBILICAL)

      Experimental hematology
    13. LAGNEAUX L; DELFORGE A; BRON D; DEBRUYN C; STRYCKMANS P
      CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) B-LYMPHOCYTES BUT NOT NORMAL B-LYMPHOCYTES ARE RESCUED FROM APOPTOSIS BY CONTACT WITH BONE-MARROW STROMAL CELLS

      Experimental hematology
    14. ARCHIMBAUD E; MICHALLET M; PHILIP L; CHARRIN C; CLAPISSON G; BELHABRI A; GUILHOT F; STRYCKMANS P; ADELEINE P; FIERE D
      G-CSF (FILGRASTIM) ADMINISTERED IN ADDITION TO INTERFERON-ALPHA (IF) TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS (PBSC) FOR AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA (CML)

      Experimental hematology
    15. ZITTOUN R; SUCIU S; WATSON M; SOLBU G; MUUS P; MANDELLI F; STRYCKMANS P; PEETERMANS M; THALER J; RESEGOTTI L; DARDENNE M; WILLEMZE R
      QUALITY-OF-LIFE IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA IN PROLONGED FIRST COMPLETE REMISSION AFTER BONE-MARROW TRANSPLANTATION (ALLOGENEIC OR AUTOLOGOUS) OR CHEMOTHERAPY - A CROSS-SECTIONAL STUDY OF THE EORTC-GIMEMA AML 8A TRIAL

      Bone marrow transplantation
    16. TRENSCHEL R; BERNIER M; STRYCKMANS P; VERHEST A; BADJOU R; CROMBEZ P; BRON D
      COMPLETE REMISSION FOLLOWING DONOR PBSC AFTER LOW-DOSE CYTARABINE CHEMOTHERAPY FOR EARLY RELAPSE OF ACUTE MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION

      Bone marrow transplantation
    17. ARCHIMBAUD E; MICHALLET M; PHILIP I; CHARRIN C; CLAPISSON G; BELHABRI A; GUILHOT F; STRYCKMANS P; ADELEINE P; FIERE D
      GRANULOCYTE-COLONY-STIMULATING FACTOR GIVEN IN ADDITION TO INTERFERON-ALPHA TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS FOR AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA

      British Journal of Haematology
    18. LAGNEAUX L; DELFORGE A; BRON D; MASSY M; BERNIER M; STRYCKMANS P
      HETEROGENOUS RESPONSE OF B-LYMPHOCYTES TO TRANSFORMING GROWTH-FACTOR-BETA IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - CORRELATION WITH THE EXPRESSION OF TGF-BETA RECEPTORS

      British Journal of Haematology
    19. LOWENBERG B; SUCIU S; ARCHIMBAUD E; OSSENKOPPELE G; VERHOEF GEG; VELLENGA E; WIJERMANS P; BERNEMAN Z; DEKKER AW; STRYCKMANS P; SCHOUTEN H; JEHN U; MUUS P; SONNEVELD P; DARDENNE M; ZITTOUN R
      USE OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR DURING AND AFTER REMISSION INDUCTION CHEMOTHERAPY IN PATIENTS AGED 61 YEARS AND OLDER WITH ACUTE MYELOID-LEUKEMIA (AML) - FINAL REPORT OF AML-11, A PHASE-III RANDOMIZED STUDY OF THE LEUKEMIA COOPERATIVE GROUP OFANIZATION-FOR-THE-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC-LCG) AND THE DUTCH BELGIAN HEMATOONCOLOGY COOPERATIVE GROUP (HOVON)

      Blood
    20. DEBRUYN C; BRON D; STRYCKMANS P; DELFORGE A
      CHARACTERIZATION OF CD34(-) CELLS FROM UMBILICAL-CORD BLOOD, BONE-MARROW AND MOBILIZED PERIPHERAL-BLOOD BEFORE AND AFTER STIMULATION BY SCF+IL-3()CD38(+) AND OF CD34(+)CD38()

      Blood
    21. STRYCKMANS P; SUCIU S; ANNINO L; SAGLIO G; MUUS P; MARIE JP; DOMBRET H; GAMBERT J; SOLBU G; DARDENNE M; MANDELLI F; FIERE D
      MOLECULAR EVALUATION OF CONSOLIDATION THERAPY AND EARLY ALLOGRAFT OR AUTOGRAFT FOR BCR-ABL(POS) ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) PATIENTS - A PILOT-STUDY OF EIGLE (EUROPEAN INTERGROUP OF GIMEMA, FRENCHLALA AND EORTC)

      Blood
    22. LAGNEAUX L; DELFORGE A; BRON D; DEBRUYN C; STRYCKMANS P
      B-CHRONIC LYMPHOCYTIC LEUKEMIC-CELLS ARE PROTECTED FROM SPONTANEOUS APOPTOSIS AFTER ADHESION TO BONE-MARROW STROMA - ROLE OF BETA-1 AND BETA-2 INTEGRINS

      Blood
    23. ZITTOUN R; SUCIU S; MANDELLI F; DEWITTE T; THALER J; STRYCKMANS P; HAYAT M; PEETERMANS M; CADIOU M; SOLBU G; PETTI MC; WILLEMZE R
      GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ASSOCIATED WITH INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A RANDOMIZED TRIAL BY THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LEUKEMIA COOPERATIVE GROUP

      Journal of clinical oncology
    24. DEBRUYN C; STRYCKMANS P; BRON D; MASSY M; BERNIER M; DEHEMPTINNE D; DELFORGE A
      CELL-CYCLE STATUS AND KINETICS OF CD34(-BLOOD AND BONE-MARROW() SUBPOPULATIONS FROM CORD)

      Experimental hematology
    25. LAGNEAUX L; DELFORGE A; BOSMANS E; BRUGGEMAN C; SNOECK R; STRYCKMANS P; BRON D
      RECOMBINANT PROTEINS OF HUMAN CYTOMEGALOVIRUS (GB, PP65, AND PP150) INCREASE CONSTITUTIVE PRODUCTION OF IL-6 AND LIF BY BONE-MARROW STROMALCELLS

      Experimental hematology
    26. LAGNEAUX L; DELFORGE A; BRON D; DEBRUYN C; DORVAL C; MASSY M; BERNIER M; STRYCKMANS P
      CHRONIC LYMPHOCYTIC LEUKEMIC (CLL) B-LYMPHOCYTES ADHERING TO BONE-MARROW STROMAL CELLS ARE PROTECTED FROM APOPTOSIS

      Experimental hematology
    27. BIERNAUX C; SELS A; HUEZ G; STRYCKMANS P
      VERY-LOW LEVEL OF MAJOR BCR-ABL EXPRESSION IN BLOOD OF SOME HEALTHY-INDIVIDUALS

      Bone marrow transplantation
    28. LAGNEAUX L; DELFORGE A; SNOECK R; BOSMANS E; SCHOLS D; DECLERCY E; STRYCKMANS P; BRON D
      IMBALANCE IN PRODUCTION OF CYTOKINES BY BONE-MARROW STROMAL CELLS FOLLOWING CYTOMEGALOVIRUS-INFECTION

      The Journal of infectious diseases
    29. SARFATI M; CHEVRET S; CHASTANG C; BIRON G; STRYCKMANS P; DELESPESSE G; BINET JL; MERLEBERAL H; BRON D
      PROGNOSTIC IMPORTANCE OF SERUM-SOLUBLE CD23 LEVEL IN CHRONIC LYMPHOCYTIC-LEUKEMIA

      Blood
    30. DEBRUYN C; DELFORGE A; BRON D; BERNIER M; STRYCKMANS P
      CELL-CYCLE STATUS AND KINETICS OF CD34(-CORD BLOOD, BONE-MARROW AND MOBILIZED PERIPHERAL-BLOOD() SUBPOPULATIONS FROM UMBILICAL)

      Blood
    31. LAGNEAUX L; DELFORGE A; BOSMANS E; BRUGGEMAN C; SNOECK R; STRYCKMANS P; BRON D
      DISTURBANCE OF CYTOKINE RELEASE BY BONE-MARROW STROMAL CELLS AFTER EXPOSURE TO RECOMBINANT PROTEINS OF HU CMV (GB, PP65 AND PP150)

      Blood
    32. TRENSCHEL R; BERNIER M; MASSY M; MAEREVOET M; DEHEMRICOURT EL; DELFORGE A; BADJOU R; STRYCKMANS P; BRON D
      MYELOID AND LYMPHOID RECOVERY AFTER ALLOGENEIC RELATED, UNRELATED BONE-MARROW AND RELATED PERIPHERAL STEM-CELL TRANSPLANTATION

      Blood
    33. MUUS P; ZITTOUN R; HAYAT M; MANDELLI F; WILLEMZE R; DEWITTE T; STRYCKMANS P; LABAR B; BERNEMAN Z; ARCHIMBAUD E; PETTI MC; JEHN U; SOLBU G; DARDENNE M; SUCIU S
      LONG-TERM SURVIVORS AFTER AML - FOLLOW-UP ON SURVIVAL AND LATE SIDE-EFFECTS OF THE AML5, AML6 AND AML8 STUDIES OF THE EORTC LEUKEMIA COOPERATIVE GROUP AND THE GIMEMA

      Blood
    34. LAGNEAUX L; DELFORGE A; BRON D; DEBRUYN C; DORVAL C; BERNIER M; STRYCKMANS P
      CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) CD19(-MARROW STROMAL CELLS()CD5(+)LYMPHOCYTES BUT NOT NORMAL CD19(+)CD5(+) LYMPHOCYTES ARE RESCUED FROMAPOPTOSIS BY CONTACT WITH BONE)

      Blood
    35. BERNIER M; SUCIU S; STRYCKMANS P; DEWITTE T; DARDENNE M; SOLBU G; VEGNA ML; WILLEMZE R; MANDELLI F; ZITTOUN R
      IMMUNOPHENOTYPE OF THE EORTC GIMEMA AML-10 PROTOCOL - CLINICAL RELEVANCE AND CYTOGENETIC CORRELATION/

      Blood
    36. LAGNEAUX L; DELFORGE A; SNOECK R; BOSMANS E; MOREAU JF; TAUPIN JL; DECLERCQ E; STRYCKMANS P; BRON D
      HUMAN CYTOMEGALOVIRUS INCREASES CONSTITUTIVE PRODUCTION OF INTERLEUKIN-6 AND LEUKEMIA INHIBITORY FACTOR BY BONE-MARROW STROMAL CELLS

      Blood
    37. PRAET M; STRYCKMANS P; RUYSSCHAERT JM
      CELLULAR UPTAKE, CYTOTOXICITY, AND TRANSPORT KINETICS OF ANTHRACYCLINES IN HUMAN SENSITIVE AND MULTIDRUG-RESISTANT K562 CELLS

      Biochemical pharmacology
    38. DEBRUYN C; DELFORGE A; BRON D; BERNIER M; MASSY M; LEY P; DEHEMPTINNE D; STRYCKMANS P
      COMPARISON OF THE COEXPRESSION OF CD38, CD33 AND HLA-DR ANTIGENS ON CD34(-BLOOD AND BONE-MARROW() PURIFIED CELLS FROM HUMAN CORD)

      Stem cells
    39. BERNIER M; MASSY M; DELEEUW N; BRON D; DEBUSSCHER L; STRYCKMANS P
      IMMUNOLOGICAL DEFINITION OF ACUTE MINIMALLY DIFFERENTIATED MYELOID-LEUKEMIA (MO) AND ACUTE UNDIFFERENTIATED LEUKEMIA (AUL)

      Leukemia & lymphoma
    40. LAGNEAUX L; DELFORGE A; BRON D; BOSMANS E; STRYCKMANS P
      COMPARATIVE-ANALYSIS OF CYTOKINES RELEASED BY BONE-MARROW STROMAL CELLS FROM NORMAL DONORS AND B-CELL CHRONIC LYMPHOCYTIC LEUKEMIC PATIENTS

      Leukemia & lymphoma
    41. DELFORGE A; LAGNEAUX L; DJEUDJANG J; BRON D; STRYCKMANS P
      THE TETRAPEPTIDE ACSDKP (SERASPENIDE) REDUCES THE IN-VITRO TOXICITY OF MAFOSFAMIDE (ASTA-Z) TO BONE-MARROW STROMAL CELLS

      Experimental hematology
    42. DEBRUYN C; VANDERBEQUE A; BRON D; VEKEMANS J; STRYCKMANS P; DELFORGE A
      RECOMBINANT HUMAN INTERLEUKIN-11 - ITS IN-VIVO EFFECTS ON CORD-BLOOD AND BONE-MARROW CLONOGENIC PROGENITOR CELLS

      Experimental hematology
    43. ZITTOUN RA; MANDELLI F; WILLEMZE R; DEWITTE T; LABAR B; RESEGOTTI L; LEONI F; DAMASIO E; VISANI G; PAPA G; CARONIA F; HAYAT M; STRYCKMANS P; ROTOLI B; LEONI P; PEETERMANS ME; DARDENNE M; VEGNA ML; PETTI MC; SOLBU G; SUCIU S
      AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH INTENSIVE CHEMOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA

      The New England journal of medicine
    44. BIERNAUX C; LOOS M; SELS A; HUEZ G; STRYCKMANS P
      DETECTION OF MAJOR BCR-ABL GENE-EXPRESSION AT A VERY-LOW LEVEL IN BLOOD-CELLS OF SOME HEALTHY-INDIVIDUALS

      Blood
    45. ZITTOUN R; SUCIU S; SOLBU G; WATSON M; MUUS P; MANDELLI F; STRYCKMANS P; PEETERMANS M; THALER J; WILLEMZE R
      COMPARISON OF QUALITY-OF-LIFE (QOL) OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIAS (AML) IN LONG-TERM FIRST COMPLETE REMISSION (CR) AFTER BONE-MARROW TRANSPLANTATION (BMT) - ALLOGENEIC OR AUTOLOGOUS - OR INTENSIVE CHEMOTHERAPY CONSOLIDATION (ICC) - EORTC-GIMEMA AML 8A STUDY

      Blood
    46. LOWENBERG B; SUCIU S; ZITTOUN R; OSSENKOPPELE G; BOOGAERTS MA; WIJERMANS P; VELLENGA E; BERNEMAN Z; DEFFER AW; SONNEVELD P; STRYCKMANS P; SOLBU G; DARDENNE M; DEWITTE T; ARCHIMBAUD E
      GM-CSF DURING AS WELL AS AFTER INDUCTION CHEMOTHERAPY (CT) IN ELDERLYPATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) - THE EORTC-HOVON PHASE-III TRIAL (AML-11)

      Blood
    47. MERLEBERAL H; CHEVRET S; BIRON G; STRYCKMANS P; CHASTANG C; DELESPESSE G; BINET JL; BRON D; SARFATI M
      PROGNOSTIC IMPORTANCE OF SERUM-SOLUBLE CD23 LEVEL IN CHRONIC LYMPHOCYTIC-LEUKEMIA

      Blood
    48. STRYCKMANS P; MARIE JP; MUUS P; FILLET G; SOLBU G; SUCIU S
      EVALUATION OF THE QUALITY OF PERIPHERAL-BLOOD PROGENITORS (PBP) FOR AUTOLOGOUS TRANSPLANTATION IN ADULT PHILADELPHIA-POSITIVE (PH-LEUKEMIA (ALL) - A PILOT-STUDY() ACUTE LYMPHOBLASTIC)

      Blood
    49. DEBRUYN C; DELFORGE A; BRON D; LEY P; DEHEMPTINNE D; STRYCKMANS P
      MODULATION OF HUMAN CORD-BLOOD PROGENITOR-CELL GROWTH BY RECOMBINANT HUMAN INTERLEUKIN-3 (IL-3), IL-6, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AND STEM-CELL FACTOR (SCF) IN SERUM-SUPPLEMENTEDAND SERUM-FREE MEDIUM

      Stem cells
    50. ZITTOUN R; MANDELLI E; WILLEMZE R; DEWITTE T; LABAR B; RESEGOTTI L; FERRINI R; VISANI G; CARONIA E; STRYCKMANS P; MARMONT A; HAYAT M; UMLAUFT F; ROTOLI B; PEETERMANS M; PAPA LP; PETTI MC; DARDENNE M; SOLBU G; VEGNA ML; SUCIU S
      EORTC-GIMEMA AML8 PROTOCOL - A PHASE-III STUDY ON AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA (AML)

      Leukemia & lymphoma
    51. DEBRUYN C; STRYCKMANS P; BRON D; BERNIER M; MASSY M; LEY P; DEHEMPTINNE D; DELFORGE A
      EXPANSION OF PURIFIED CD34-BLOOD CELLS IN STROMAL CELL-FREE LONG-TERMCULTURES IN PRESENCE OF RECOMBINANT GROWTH-FACTORS( CORD)

      Experimental hematology
    52. LAGNEAUX L; DELFORGE A; BRON D; STRYCKMANS P
      ACTIVITY OF TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)

      Experimental hematology
    53. LAGNEAUX L; DELFORGE A; SNOECK R; SCHOLS D; BOSMANS E; DECLERCQ E; STRYCKMANS P; BRON D
      DIFFERENTIAL EFFECT OF CYTOMEGALOVIRUS (CMV) ON G-CSF, GM-CSF, IL-6, IL-10 AND TGF-BETA PRODUCTION BY HUMAN BONE-MARROW STROMAL CELLS

      Experimental hematology
    54. LAGNEAUX L; DELFORGE A; SNOECK R; STRYCKMANS P; BRON D
      DECREASED PRODUCTION OF CYTOKINES AFTER CYTOMEGALOVIRUS-INFECTION OF MARROW-DERIVED STROMAL CELLS

      Experimental hematology
    55. RAVOET C; DEGREVE J; VANDEWOUDE K; KERGER J; SCULIER JP; LACOR P; STRYCKMANS P; PICCART M
      TUMOR STIMULATING EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-6

      Lancet
    56. STRYCKMANS P; MUUS P; MARIE JP; FILLET G; LABAR B; PEETERMANS M; KURSTJENS J; EFIRA A; PAULUS R; ROOZENDAAL K; SCHAAFSMA R; JAKSIC B; FEREMANS W; VERHEST A; BERNIER M; DARDENNE M; SOLBU G; DEWITTE T; ZITTOUN R; SUCIU S
      ADULT PH-LEUKEMIA IN ALL-3 EORTC STUDY( ACUTE LYMPHOBLASTIC)

      Blood
    57. ZITTOUN R; MANDELLI F; DEWITTE T; WILLEMZE R; THALER J; HAYAT M; STRYCKMANS P; PEETERMANS M; DARDENNE M; SOLBU G; SUCIU S
      RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) DURING INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) - A RANDOMIZED TRIAL FROM EORTC-GIMEMA LEUKEMIA COOPERATIVE GROUPS

      Blood
    58. DEBRUYN C; STRYCKMANS P; BERNIER M; MASSY M; DELEEUW N; BRON D; LEY P; DEHEMPTINNE D; DELFORGE A
      EXPANSION OF PURIFIED CD34-BLOOD CELLS IN STROMAL CELL-FREE LONG-TERMCULTURES( CORD)

      Blood
    59. TANGHE A; DELFORGE A; BERNIER M; MASSY M; DELEEUW N; BRON D; STRYCKMANS P
      APOPTOSIS OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) CELLS IN PRESENCE OF VARIOUS AGENTS AND ITS MODULATION BY INTERLEUKIN-4

      Blood
    60. DEBRUYN C; STRYCKMANS P; BERNIER M; MASSY M; DELEEUW N; BRON D; LEY P; DEHEMPTINNE D; DELFORGE A
      COEXPRESSION OF CD38, CD33 AND HLA-DR ANTIGENS ON HUMAN CORD-BLOOD AND BONE-MARROW CD34+ CELLS

      Blood
    61. LAGNEAUX L; DELFORGE A; SNOECK R; BOSMANS E; MOREAU JF; DECLERCQ E; STRYCKMANS P; BRON D
      DISREGULATION IN THE CYTOKINE-NETWORK OF HUMAN BONE-MARROW STROMAL CELLS AFTER CYTOMEGALOVIRUS (CMV) INFECTION

      Blood
    62. LAGNEAUX L; DELFORGE A; BRON D; STRYCKMANS P
      CONTROL OF B-LYMPHOCYTE PROLIFERATION BY TRANSFORMING GROWTH-FACTOR-BETA (TGF-B) IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)

      Blood
    63. RAVOET C; DEGREVE J; STRYCKMANS P; LACOR P; KERGER J; SCULIER JP; VANDEWOUDE K; LIPS S; BLANK A; ALEXIOU J; PICCART M
      POTENTIAL IN-VIVO GROWTH-STIMULATION OF HUMAN SOLID TUMORS BY RECOMBINANT HUMAN INTERLEUKIN-6 (RHIL-6)

      Blood
    64. BEX F; HERMANS P; SPRECHER S; ACHOUR A; BADJOU R; DESGRANGES C; COGNIAUX J; FRANCHIOLI P; VANHULLE C; LACHGAR A; STRYCKMANS P; ZAGURY D; BURNY A; CLUMECK N
      SYNGENEIC ADOPTIVE TRANSFER OF ANTI-HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1)-PRIMED LYMPHOCYTES FROM A VACCINATED HIV-SERONEGATIVE INDIVIDUALTO HIS HIV-1-INFECTED IDENTICAL TWIN

      Blood
    65. STRYCKMANS P; DUFF GW; FRACCHIA GN
      EFFICACY AND SAFETY OF CYTOKINES FOR HUMAN THERAPY - REPORT OF AN EC STUDY-GROUP

      Cytokine
    66. RAZAVI D; DELVAUX N; BREDART A; AUTIER P; BRON D; DEBUSSCHER L; STRYCKMANS P
      PROFESSIONAL REHABILITATION OF LYMPHOMA PATIENTS - A STUDY OF PSYCHOSOCIAL FACTORS ASSOCIATED WITH RETURN TO WORK

      Supportive care in cancer
    67. GRIESSHAMMER M; HEHLMANN R; HOCHHAUS A; TALPAZ M; TURA S; STRYCKMANS P; ALLAN NC; TANZER J; KOLB HJ; HEIMPEL H
      INTERFERON IN CHRONIC MYELOID-LEUKEMIA - A WORKSHOP REPORT

      Annals of hematology
    68. DELFORGE A; LAGNEAUX L; DORVAL C; BRON D; BOSMANS E; STRYCKMANS P
      EXCESSIVE PRODUCTION OF TGF-BETA BY BONE-MARROW STROMAL CELLS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) INHIBITS GROWTH OF HEMATOPOIETIC PRECURSORS AND IL-6 PRODUCTION

      Experimental hematology
    69. DEBRUYN C; STRYCKMANS P; BERNIER M; MASSY M; LEY P; DEGUELDRE M; BRON D; DELFORGE A
      AMPLIFICATION OF CORD-BLOOD CD34(-FREE LONG-TERM CULTURES IN PRESENCEOF GROWTH-FACTORS (GFS)() PURIFIED CELLS ON STROMAL CELL)

      Experimental hematology
    70. DEBRUN C; STRYCKMANS P; BRON D; LEY P; DEGUELDRE M; DELFORGE A
      MODULATION OF CORD-BLOOD CFU-GM GROWTH BY HEMATOPOIETIC GROWTH-FACTORS IN FCS-SUPPLEMENTED AND FCS-FREE CULTURE

      Experimental hematology
    71. LAGNEAUX L; DELFORGE A; STRYCKMANS P; BRON D
      CYTOMEGALOVIRUS-MEDIATED MYELOSUPPRESSION

      Experimental hematology
    72. SARFATI M; BIRON G; LELEUX A; JACQUY C; PAESMANS M; STRYCKMANS P; FONTEYN C; ARMANT M; DELESPESSE G; BRON D
      SERUM SOLUBLE CD23 (SCD23) IS A PROGNOSTIC MARKER IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)

      The Journal of immunology
    73. LAGNEAUX L; DELFORGE A; DORVAL C; BRON D; STRYCKMANS P
      EXCESSIVE PRODUCTION OF TRANSFORMING GROWTH-FACTOR-BETA BY BONE-MARROW STROMAL CELLS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA INHIBITS GROWTHOF HEMATOPOIETIC PRECURSORS AND INTERLEUKIN-6 PRODUCTION

      Blood
    74. ZITTOUN R; MANDELLI F; WILLEMZE R; DEWITTE T; LABAR B; RESEGOTTI L; FERRINI PR; VISANI G; CARONIA F; STRYCKMANS P; MARMONT A; HAYAT M; UMLAUFT F; ROTOLI B; PEETERMANS M; PAPA G; LEONI P; PETTI MC; DARDENNE M; SOLBU G; VEGNA ML; SUCIU S
      PROSPECTIVE PHASE-III STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION(ABMT) NU SHORT INTENSIVE CHEMOTHERAPY (IC) V ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO-BMT) DURING 1ST COMPLETE REMISSION (CR) OF ACUTEMYELOGENOUS LEUKEMIA (AML) - RESULTS OF THE EORTC-GIMEMA AML-8A TRIAL

      Blood
    75. DEBRUYN C; DELFORGE A; BERNIER M; MASSY M; BRON D; LEY P; DEHEMPTINNE D; STRYCKMANS P
      EXPANSION OF PURIFIED CD34(-BLOOD CELLS IN STROMAL CELL-FREE LONG-TERM CULTURES IN PRESENCE OF RECOMBINANT GROWTH-FACTORS() CORD)

      Blood
    76. BIERNAUX C; LOOS M; SELS A; VELU T; VERHEST A; HUEZ G; STRYCKMANS P
      A CASE OF PH' POSITIVE CHRONIC MYELOID-LEUKEMIA (CML) WITH FEW HEMATOLOGICAL SIGNS AND LOW EXPRESSION OF THE BCR-ABL FUSION GENE INCIPIENT CML - A DISTINCT PHASE OF THE DISEASE

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 18:29:39